Indianapolis, Indiana

Indianapolis has solidified its reputation as a premier global life sciences hub, driven by a powerful synergy between corporate titans, elite academic research and a rapidly expanding biotechnology startup ecosystem.

As the home to the global headquarters of Eli Lilly and Company, the city is a powerhouse in pharmaceutical manufacturing and drug discovery, particularly within the realms of oncology, neuroscience and diabetes care.

Beyond pharmaceuticals, the region is a leader in medical device innovation, anchored by the "Orthopedic Capital of the World" just to its north and a dense cluster of medtech companies specializing in precision instruments and diagnostics.

The 16 Tech Innovation District serves as the city’s urban heartbeat for healthcare innovation, fostering collaboration between the Indiana University School of Medicine and private-sector disruptors. Bolstered by world-class academic research institutions like Purdue University and Indiana University, the ecosystem excels in translating laboratory breakthroughs into commercialized digital health and biopharmaceutical solutions.

With over $99 billion in annual economic impact, Indianapolis offers a robust talent pipeline and state-of-the-art biomanufacturing facilities that attract significant venture capital and international partnerships.

This "Crossroads of America" now leads the charge in personalized medicine and radiopharmaceuticals, making it an indispensable destination for global life sciences investment.